Tag: CRISPR/CAS9 gene editing

Bayer in Gene Therapy Collaboration With Mammoth Biosciences By Reuters January 10, 2022 Updated: January 10, 2022 FRANKFURT—Bayer on Monday struck a partnership deal with Mammoth Biosciences to develop therapeutic tools based on CRISPR/CAS9 gene editing as the German drug maker seeks to widen its cell and gene therapy development efforts. Unlisted U.S. biotech firm Mammoth will initially receive $40…